IPO Year: 2024
Exchange: NASDAQ
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/21/2024 | $15.00 | Buy | BTIG Research |
3/6/2024 | $13.00 | Buy | HSBC Securities |
2/27/2024 | $11.50 | Hold → Buy | Deutsche Bank |
2/20/2024 | $15.00 | Buy | Guggenheim |
2/20/2024 | $15.00 | Outperform | Leerink Partners |
2/20/2024 | $15.00 | Buy | UBS |
2/20/2024 | $14.00 | Buy | BofA Securities |
2/20/2024 | $14.00 | Buy | UBS |
2/20/2024 | $18.00 | Overweight | Morgan Stanley |
2/20/2024 | $15.00 | Overweight | Wells Fargo |
LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that on April 24, 2024, BrightSpring appointed Timothy A. Wicks as a new member of the Board of Directors. Mr. Wicks will assume his new role effective immediately, bringing the Company's total Board of Directors to seven members, including two independent directors. Mr. Wicks brings over 20 years of executive leadership experience in the healthcare industry to BrightSpring's Board of Directors, including his most recent role as Executive Vice President
LOUISVILLE, Ky., Sept. 13, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that investment funds managed by KKR & Co. Inc. and its subsidiaries ("KKR"), an existing shareholder of BrightSpring, have entered into an agreement with Walgreen Co. ("WBA") to purchase 11,619,998 shares of BrightSpring's common stock from WBA in a private transaction. The transaction was negotiated directly between KKR and WBA, with KKR making the investment through its private equity funds. BrightSpring is not issuing or selling any shares of common stock
PITTSBURGH, Sept. 12, 2024 /PRNewswire/ -- North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company for comprehensive hospice care services in 18 counties in north central Florida completed its sale of select assets to BrightSpring Health Services (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, effective September 1, 2024. Haven Hospice's Mission remains unchanged: "Honoring life by providing comfort, care and compassion to individuals and families we serve." In a separate but related transaction, BrightSpring also acquired the Attic Resale Stores.
LOUISVILLE, Ky., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that it completed the acquisition of the assets of North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company holding a Certificate of Need (CON) for comprehensive hospice care services in 18 counties in north central Florida, effective September 1, 2024. "We are excited to welcome Haven Hospice into BrightSpring, expanding our existing hospice services into the CON state of Florida," said Bright
LOUISVILLE, Ky., Aug. 22, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference. Company management will present on Friday, September 6th at 12:20pm ET. A live and archived webcast of the event will be available on the "Event & Presentations" section of the BrightSpring investor relations website at https://ir.brightspringhealth.com/. About BrightSpring Health ServicesBrightSpring Health Services is the parent company of leading service lines that provide integrated home- and community-based pharmacy and health solutions fo
LOUISVILLE, Ky., Aug. 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the second quarter ended June 30, 2024, and increases 2024 revenue and Adjusted EBITDA1 guidance. Financial Highlights Net Revenue of $2,730 million, up 26.0% compared to $2,167 million in the second quarter of 2023.Net income of $19.4 million, compared to net income of $2.8 million in the second quarter of 2023.Adjusted EBITDA1 of $139 million, down 6.9% versus $149 million in the second quarter of 2023 When excluding a certain $3
LOUISVILLE, Ky., July 08, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced multiple of its service lines across the country have earned accreditations for its personalized, quality care that has significantly improved health outcomes for patients. Today, BrightSpring holds over 900 accreditations that recognize process and quality excellence across its operations and locations. Most recently, Rehab Without Walls, a provider of highly skilled and outcome driven rehabilitation therapies for patients with complex neuro conditions,
LOUISVILLE, Ky., July 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its second quarter 2024 financial results on Friday, August 2, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference ca
LOUISVILLE, Ky., June 24, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced a definitive agreement to acquire the assets of North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company holding a Certificate of Need (CON) for comprehensive hospice care services in 18 counties in north central Florida. "We are excited to welcome Haven Hospice into BrightSpring, bolstering our existing hospice care line of business and expanding our hospice services into the CON state of Florida
LOUISVILLE, Ky., June 03, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) today announced its $100 million equity grant as disclosed at the initial public offering (IPO), has now been awarded to approximately 20,000 of its full-time and tenured employees who were awarded with employee-specific shares. The Company first announced this broad-based employee grant on January 26 as part of its IPO, with these to-be-granted shares included in the Company's share count at the time. "We are excited and honored to award about twenty thousand of our hard-working and impactful teammates with stock grants to show our appreciation for their c
LOUISVILLE, Ky., May 22, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that Company management will participate at three upcoming investor conferences. 2024 Leerink Partners Healthcare Crossroads ConferenceFireside Chat on Thursday, May 30th at 8:40am CT Jefferies Global Healthcare ConferenceFireside Chat on Thursday, June 6th at 9am ET Goldman Sachs 45th Annual Global Healthcare ConferenceFireside Chat on Monday, June 10th at 11:20am ET Live and archived webcasts of the events will be available on the "Event & Presentations" section of the BrightSpring investor relations website at https://ir.brightspringhea
D - BrightSpring Health Services, Inc. (0001865782) (Filer)
10-Q - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
10-Q - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
10-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
LOUISVILLE, Ky., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that it completed the acquisition of the assets of North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company holding a Certificate of Need (CON) for comprehensive hospice care services in 18 counties in north central Florida, effective September 1, 2024. "We are excited to welcome Haven Hospice into BrightSpring, expanding our existing hospice services into the CON state of Florida," said Bright
LOUISVILLE, Ky., July 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its second quarter 2024 financial results on Friday, August 2, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference ca
LOUISVILLE, Ky., April 09, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its first quarter 2024 financial results on Thursday, May 2, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference cal
LOUISVILLE, Ky., Feb. 29, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights Net revenue of $2,375 million, up 20.5% compared to $1,971 million in the fourth quarter of 2022 Net revenue growth was negatively impacted by 1.6% due to the Q4 2022 Workforce Solutions divestiture Gross profit of $369 million, or 15.5% of revenue, up 9.2% compared to $338 million, or 17.1% of revenue, in the fourth quarter of 2022 Gross profit growth was negatively impacted by 1.4% due to the Q4 2022 Workforce Solutions
BTIG Research initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00
HSBC Securities initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $13.00
Deutsche Bank upgraded BrightSpring Health Services from Hold to Buy and set a new price target of $11.50
Guggenheim initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00
Leerink Partners initiated coverage of BrightSpring Health Services with a rating of Outperform and set a new price target of $15.00
UBS initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00
BofA Securities initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $14.00
UBS initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $14.00
Morgan Stanley initiated coverage of BrightSpring Health Services with a rating of Overweight and set a new price target of $18.00
Wells Fargo initiated coverage of BrightSpring Health Services with a rating of Overweight and set a new price target of $15.00
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4/A - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
3 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
The company announced a definitive agreement to acquire the assets of North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company holding a Certificate of Need (CON) for comprehensive hospice care services in 18 counties in north central Florida. otal consideration for the acquisition is $60 million, with $15 million in cash at close, $30 million in Company equity at close, and an additional $15 million in a seller note payable four years after closing.
BTIG analyst David Larsen initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and announces Price Target of $15.
Analysts' ratings for BrightSpring Health (NASDAQ:BTSG) over the last quarter vary from bullish to bearish, as provided by 11 analysts. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 6 4 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 6 3 1 0 0 Analysts have set 12-month price targets for BrightSpring Health, revealing an average target of $16.77, a high estimate of $26.00, and a low estimate of $11.50. Observing a downward trend, the current average is 18.2% low
Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $15 to $16.
BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.07 by 71.43 percent. This is a 220 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $2.577 billion which beat the analyst consensus estimate of $2.313 billion by 11.41 percent. This is a 27.07 percent increase over sales of $2.028 billion the same period last year.
On CNBC's Mad Money Lightning Round,” Jim Cramer said Dynatrace, Inc. (NYSE:DT) is “very expensive” stock, and he is not going to recommend it. On April 19, TD Cowen analyst Andrew Sherman maintained Dynatrace with a Buy and lowered the price target from $62 to $58. Canopy Growth Corporation (NASDAQ:CGC) is the “best of the pot stocks,” Cramer said, “We don't think it's worth all that much, but we do think it's the best of that lot.” On April 18, Canopy Growth announced that CBI exchanged 17,149,925 common shares in the capital of the company for exchangeable shares for no consideration When asked about BrightSpring Health Services, Inc. (NASDAQ:BTSG), he said, “That short positi
BrightSpring Health Services ("BrightSpring" or "BrightSpring Health Services") (NASDAQ:BTSG) announced today that its company Onco360®, a leading independent oncology pharmacy, was selected as a national pharmacy partner by Alexion Pharmaceuticals for a first-in-class, oral, Factor D inhibitor, Voydeya® (Danicopan) to treat patients with a rare, life-threatening disease of the blood called paroxysmal nocturnal hemoglobinuria (PNH) who are experiencing extravascular hemolysis (EVH). Voydeya® is FDA-approved as add-on therapy to Ultomiris® (Ravulizumab) or Soliris® (Eculizumab) for patients living with PNH that experience continued anemia, or EVH. This innovative drug will complement current
HSBC analyst Sidharth Sahoo initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and announces Price Target of $13.